GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
4,843
Funds Holding Change
+313
Funds Holding Growth
+7%
Value
$1.09T
Holding in Top 10
704
Top 10 Change
-23
Top 10 Growth
-3%
Value Growth
+4%
New
539
Increased
1,905
Reduced
2,117
Closed
152
Capital Inflow
$35.6B
Capital Outflow
$32.9B
Net Capital Flow
+$2.68B
Capital Flow Change
-$886M
Calls
$15.3B
Puts
$16.7B
Net Calls
-$1.47B
Put/Call Ratio
1.1